Products & Tech | Page 41 of 63

Medtronic Launches mySentry the First-Of-Its-Kind Remote Glucose Monitor

Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...

Medtronic Launches mySentry the First-Of-Its-Kind Remote Glucose Monitor

Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide...

Tranzyme Pharma, Developing a New Drug for Treatment of Diabetic Gastroparesis

Currently, there are no safe and effective drugs on the market for treating gastroparesis...

Testing the Spring Universal Infusion Set

I’ve been having some troubles with my pump. Some of the problems are my fault, like forgetting to resume the pump after suspending it for a shower,…

Eight New Diabetes Products to Look for in 2012

The new year holds promise for better (and smaller!) diabetes devices. Take a look at our favorite up-and-coming products...

Spring To Launch Special Infusion Sets for Children with Diabetes

Since its recent commercial launch, the Spring Universal Infusion Set has been particularly well received by parents of children with type 1 diabetes. Specifically, the following features were highly favored: the automatic all-in-one inserter (which gives young patients the independence to do their own site changes), the lightning-fast needle insertion...

Health on the Road: Ford’s Diabetes Car

Let’s say your blood glucose is low. Would the built in safety controls of the car ever take over and force you to pull over?

Can Metformin Reduce Cardiovascular Risk in Type 1 Diabetes Patients?

JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people with type 1 diabetes...

New Studies Show Novo Nordisk’s Combination Insulin Reduces Hypoglycemia

A study released by Novo Nordisk at the International Diabetes Federation (IDF) 21st World Diabetes Congress in Dubai has found that the combination insulin degludec/insulin aspart, currently being developed, significantly reduced hypoglycemia in type 1 diabetes and type 2 diabetes patients...

Positive Results for Sanofi’s Lyxumia in Treatment of Type 2 Diabetes

Sanofi announced positive results from the Gel Duo 1 study of it's investigational GLP-1 agonist, Lyxumia (lixisenatide) in the treatment of type 2 diabetes patients. The results show that patients with type 2 diabetes uncontrolled on oral anti-diabetics (OADs) – mainly metformin - significantly reduced their HbA1c levels when...